Molecular and biological characteristics of laboratory metconazole-resistant mutants in Fusarium graminearum.

The Fusarium graminearum species complex (FGSC), the causal agents of Fusarium head blight (FHB) in wheat, has the different geographically distributed species. Our previous study suggested that a DMI fungicide metconazole exhibits a strong fungicidal activity in mycelial growth of Chinese FHB pathogens and metconazole is currently a most effective compound of commercial fungicides for controlling FHB in China. In the current study, metconazole-resistant F. graminearum mutants were induced by chemical taming and their molecular and biological characteristics were determined. Compared to the corresponding parental strains, three mutation genotypes (two single mutations G443S and D243N, and a combined mutation E103Q&V157 L) were observed in the FgCYP51A of metconazole-resistant mutants. In addition to FgCYP51A mutation, all the mutants had no change on sequences of FgCYP51B and FgCYP51C and promotor sequences of FgCYP51s, but expression patterns of FgCYP51s were different. Compared to the corresponding parental strains, overexpression of FgCYP51A, FgCYP51B and FgCYP51C was observed in the mutant conferring D243N mutation, overexpression of FgCYP51A and FgCYP51B was observed in the mutant conferring E103Q&V157L mutations, and overexpression of FgCYP51A was observed in the mutant conferring G443S mutation. Biological fitness of the mutants conferring D243N mutation or E103Q&V157 L mutations significantly decreased in comparison to the corresponding parental strains, suggesting a fitness penalty. The mutants conferring G443S mutation had no change in biological fitness as compared with the parental strain, indicating that the G443S mutation may emerge in field resistant populations of F. graminearum in the future. In addition, a positive cross resistance between metconazole and other tested DMI fungicides was observed in the mutants conferring D243N mutation or E103Q&V157L mutations, but no cross resistance between metconazole and ipconazole or prochloraz was observed in the mutants conferring G443S mutation. Therefore, we concluded that the mutation genotype of FgCYP51A may cause the differences of biological fitness, cross-resistance and FgCYP51s overexpression patterns. Such information will increase our understanding of resistance mechanism of F. graminearum to DMIs and could provide new reference data for the management of FHB.